Remove Behavioural Health Remove Marketing Remove Pharma Production Remove Production
article thumbnail

Orexo eyes opioid use disorder app launch before year-end

pharmaphorum

Like its earlier digital therapies for alcohol misuse and depression , Modia’s earlier-than-expected rollout stems from legislation that has made it possible to secure reimbursement for certain digital products for psychiatric disorders during the COVID-19 pandemic.